Poster: CML-227: Pilot Study on a Response-Directed Switch from Nilotinib to Imatinib in Newly Diagnosed Chronic Myeloid Leukemia

Clinical Lymphoma Myeloma and Leukemia(2021)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要